News
The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results